Literature DB >> 27163854

Potential anti-obesity effects of a long-acting cocaine hydrolase.

Xirong Zheng1, Jing Deng1, Ting Zhang1, Jianzhuang Yao1, Fang Zheng2, Chang-Guo Zhan3.   

Abstract

A long-acting cocaine hydrolase, known as CocH3-Fc(M3), engineered from human butyrylcholinesterase (BChE) was tested, in this study, for its potential anti-obesity effects. Mice on a high-fat diet gained significantly less body weight when treated weekly with 1 mg/kg CocH3-Fc(M3) compared to control mice, though their food intake was similar. There is no correlation between the average body weight and the average food intake, which is consistent with the previously reported observation in BChE knockout mice. In addition, molecular modeling was carried out to understand how ghrelin binds with CocH3, showing that ghrelin binds with CocH3 in a similar mode as ghrelin binding with wild-type human BChE. The similar binding structures explains why CocH3 and BChE have similar catalytic activity against ghrelin. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Appetite control; Cocaine hydrolase; Enzyme; Hormone; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27163854      PMCID: PMC5097895          DOI: 10.1016/j.cbi.2016.05.010

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  39 in total

1.  Overweight and obesity worldwide now estimated to involve 1.7 billion people.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

2.  Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice.

Authors:  Lauren P Shearman; Sheng-Ping Wang; Steffen Helmling; D Sloan Stribling; Paul Mazur; Lan Ge; Liyang Wang; Sven Klussmann; D Euan Macintyre; Andrew D Howard; Alison M Strack
Journal:  Endocrinology       Date:  2005-12-08       Impact factor: 4.736

3.  Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.

Authors:  Lawrence M Schopfer; Oksana Lockridge; Stephen Brimijoin
Journal:  Gen Comp Endocrinol       Date:  2015-06-12       Impact factor: 2.822

4.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

5.  The butyrylcholinesterase knockout mouse is obese on a high-fat diet.

Authors:  Bin Li; Ellen G Duysen; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2008-03-22       Impact factor: 5.192

6.  Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene.

Authors:  Shurong Hou; Max Zhan; Xirong Zheng; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-06-15       Impact factor: 3.857

7.  Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999-2010.

Authors:  Sharon Saydah; Kai McKeever Bullard; Yiling Cheng; Mohammed K Ali; Edward W Gregg; Linda Geiss; Giuseppina Imperatore
Journal:  Obesity (Silver Spring)       Date:  2014-04-15       Impact factor: 5.002

Review 8.  New pharmacological treatments for the management of obesity.

Authors:  Ryan T Hurt; Jithinraj Edakkanambeth Varayil; Jon O Ebbert
Journal:  Curr Gastroenterol Rep       Date:  2014

9.  Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.

Authors:  Orit Cohen-Barak; Jacqueline Wildeman; Jeroen van de Wetering; Judith Hettinga; Petra Schuilenga-Hut; Aviva Gross; Shane Clark; Merav Bassan; Yossi Gilgun-Sherki; Boaz Mendzelevski; Ofer Spiegelstein
Journal:  J Clin Pharmacol       Date:  2015-01-12       Impact factor: 3.126

10.  Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuse.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  PLoS Comput Biol       Date:  2012-07-26       Impact factor: 4.475

View more
  1 in total

1.  Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Michael B Stout; Michael D Jensen; Stephen Brimijoin
Journal:  Endocrinology       Date:  2016-06-14       Impact factor: 4.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.